Device infection as a materials problem: surfaces built to shake bacteria loose

The University of Tennessee, Knoxville has published an account of work by Dacheng Ren, who heads its Department of Biomedical Engineering, on what his group calls active topography: flexible implant surfaces that can be actuated by temperature change or magnetic field so that bacteria never get a stable place to settle ^[1][7]. The framing matters more than the novelty, because it moves device-associated infection out of the pharmacology column and into the materials column, and the numbers on the pharmacology side are bad.

A biofilm is a layer of bacteria wrapped in a matrix that both glues the cells to a surface and shields them; forming one makes those cells 1,000 times less susceptible to antibiotics ^[3][2]. The other thousandfold sits at the front end: according to the source, the number of bacteria needed to establish an infection on an implanted device is 1,000 times lower than the number needed to infect living tissue ^[10]. Those two factors are independent and point the same way, one lowering the dose required to start an infection and the other raising the dose required to end it ^[18]. The clinical consequence is already visible: more than half of health care-associated infections in hospitalized Americans involve medical devices ^[11], with catheters, replacement heart valves and orthopedic implants among the usual hosts, sometimes leading to severe illness or death ^[4].

Ren's argument for why conventional implants lose is mechanical, not chemical. Metals and polymers are static, he says, while human tissue moves and mounts active responses to invading microbes, a defense conventional biomaterials do not have ^[12]. His group's answer, patented a few years ago, mimics cilia: a surface of micron-sized pillars that can be driven to beat rhythmically, making the whole surface shudder and removing more than 99.9% of attached bacteria and biofilms ^[13]. In 2025, working with colleagues at Syracuse, the team coated the ciliated material in mucin, a protein that helps human cells repel bacteria ^[14]. The claimed performance includes dislodging up to 99.9% of an already established biofilm, not just preventing formation ^[8].

The starting point was an accident. Ren says a project he handed students about 10 years ago did not give the expected result, and the follow-up showed that bacteria sense surface topography and effectively decide whether to build a biofilm on it ^[6][5]. That is the load-bearing scientific claim: if attachment is a decision keyed to geometry, geometry is a control variable.

What is actually being built now is narrower than the framing. The lab is developing a prototype self-cleaning urinary catheter ^[9], a sensible first target because catheters drain urine for patients who cannot reach a bathroom or control their bladder and are rapidly colonized by biofilm-forming bacteria ^[15][16]. Ren's own summary is that an implant surface can be the cause of biofilm infection or, engineered differently, the solution ^[17].

Read the percentages with care. The university account does not name the organisms tested, does not say whether the removal figures come from bench models, animals or patients, and reports no clinical results. A 99.9% clearance in a flow cell and a 99.9% clearance inside a colonized bladder are not the same measurement, and the source does not distinguish them.